Skip to main content
SEED INNOVATIONS LIMITED logo

SEED INNOVATIONS LIMITED — Investor Relations & Filings

Ticker · SEED ISIN · GB00B7VX6J75 LEI · 213800KV6ETTB1BRZ435 IL Financial and insurance activities
Open in API
Filings indexed 467 across all filing types
Latest filing 2022-11-02 Regulatory Filings
Country GG Guernsey
Listing IL SEED

About SEED INNOVATIONS LIMITED

https://seedinnovations.co/

SEED INNOVATIONS LIMITED is an investment company specializing in early-stage ventures. The firm focuses on providing investors with exposure to disruptive life sciences and technology companies, with a developing strategic emphasis on high-growth sectors such as humanoid robotics and artificial intelligence (AI). The company actively manages its multi-sector portfolio, supporting the growth and success of its investee companies to generate long-term capital growth. Its model aims to make investment opportunities, often reserved for private venture capital firms, accessible to a broader investor base.

Recent filings

Filing Released Lang Actions
Investee Company Update: Little Green Pharma
Regulatory Filings Classification · 98% confidence The document is an official announcement disseminated via RNS (RNS Number : 1090F) from Seed Innovations Limited on November 2, 2022. The content details an update regarding an investment portfolio company (Little Green Pharma Ltd) securing funding through a placement and launching a Share Purchase Plan (SPP). This is a corporate event announcement concerning financing/capital activities of an investee company, which SEED is reporting to its shareholders/the market. Since the core subject is an update on a capital raise/financing activity of a related entity, it strongly aligns with the Capital/Financing Update (CAP) category. Although it is distributed via RNS, the specific nature of the content (fundraise details) makes CAP more precise than the general RNS fallback. The document is not a primary report (like 10-K or IR) but a specific corporate action announcement.
2022-11-02 English
Investee Company Update: Little Green Pharma Ltd
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated October 4, 2022. It details an update regarding an investee company (Little Green Pharma Ltd) and references an announcement made on the ASX. The text is structured like a press release, providing highlights and commentary from the reporting company (Seed Innovations Ltd) about a portfolio company's commercial agreement. Crucially, the footer explicitly states: "This information is provided by Reach, the non-regulatory press release distribution service of RNS... Reach announcements are identified with an orange label and the word “Reach" in the source column..." This indicates it is a general corporate announcement distributed via the RNS platform but is explicitly non-regulatory in nature. Since it is a general corporate update that doesn't fit specific categories like ER, DIV, or MANG, the most appropriate fallback category for a non-regulatory press release distributed via RNS is 'Regulatory Filings' (RNS), as per the provided definitions and the context of using the RNS distribution service for general news.
2022-10-04 English
Investee Company Update: Avextra
Capital/Financing Update Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details an update on an investee company (Avextra) raising capital via a convertible loan note, which is a material corporate event. Since this is a general regulatory announcement distributed via the RNS system and does not fit neatly into specific categories like 10-K, ER, or DIV, it falls under the general regulatory announcement category. Given the structure (RNS Number, date, brief update, contact info, and RNS disclaimer), and the fact that it is not a full report (like 10-K or IR) but a market update, the most appropriate classification is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements.
2022-10-04 English
Eurox – Change of Name to Avextra
Regulatory Filings Classification · 100% confidence The document starts with 'RNS Number : 7427Z' and contains information typical of a regulatory news service announcement, including company name, date, and contact details. The content describes a portfolio company's name change ('Eurox - Change of Name to Avextra'). Since this is a specific, non-financial operational announcement distributed via the RNS system, and it doesn't fit the criteria for specific filings like 10-K, ER, or DIV, it falls best under the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements not covered by other specific codes. The document explicitly mentions it is distributed by 'Reach, the non-regulatory press release distribution service of RNS'. Given the options, RNS (Regulatory Filings) is the most appropriate classification for a general regulatory news service release.
2022-09-16 English
Result of AGM & Updated Investor Presentation
AGM Information Classification · 99% confidence The document is a regulatory announcement (indicated by the RNS Number and RNS distribution footer) dated September 7, 2022. The title explicitly states "Result of AGM & Updated Investor Presentation". It confirms that all resolutions at the Annual General Meeting (AGM) were passed. It also mentions that an 'updated corporate presentation' is now available on the website. Since the document primarily announces the results of the AGM and points to another document (the presentation), it relates directly to AGM outcomes. The most specific code for AGM results is AGM-R (AGM Information). Although it mentions an Investor Presentation (IP), the primary focus and first announcement is the AGM result, making AGM-R the best fit over RPA or RNS, as AGM-R covers the information shared during the AGM.
2022-09-07 English
Portfolio Valuation Update & Investor Presentation
Investor Presentation Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 1544Y) on September 2, 2022. The primary content is a 'Portfolio Valuation Update' detailing the unaudited Net Asset Value (NAV) as of August 31, 2022, compared to March 31, 2022, and provides commentary on specific portfolio holdings. This strongly indicates a periodic financial update related to asset valuation. The document also mentions an 'Investor Presentation' to be held at the AGM, but the core of the filing is the valuation update itself. Since the document provides a comprehensive update on the company's net asset value, it aligns best with the Net Asset Value (NAV) classification (Code: NAV). It is not a full Annual Report (10-K) or a comprehensive Interim/Quarterly Report (IR), as it focuses specifically on portfolio valuation changes rather than full operational financial statements. It is also not just an Earnings Release (ER) which is typically just key highlights. The mention of the upcoming AGM presentation is secondary to the valuation data provided.
2022-09-02 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.